Related Experiment Video
Updated: Feb 3, 2026

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
Published on: July 20, 2022
Viridans streptococcus peritonitis in peritoneal dialysis: clinical characteristics and comparison with concurrent
Ying Liu1, Ben-Chung Cheng2, Jien-Wei Liu3
1Department of Nephrology, Tianjin First Center Hospital, No.24 Fukang Road, Nankai District, Tianjin, 300192, China.
Background:
The clinical course of Viridans streptococci (VS) peritonitis in patients undergoing peritoneal dialysis (PD) is rarely reported. This study examined the association of clinical factors with VS peritonitis.
Methods:
We retrospectively reviewed clinical data from patients with VS peritonitis from March 1990 to February 2016 in a PD center in Taiwan and evaluated clinical profiles and treatment outcomes.
Results:
A total of 109 episodes of VS peritonitis in 71 patients identified. Among these patients, 57 had mono-VS peritonitis and 14 had concurrent polymicrobial infections. The median time interval from PD initiation to the first VS peritonitis episode was 18 months (range, 0.6-144 months). Among clinical outcomes, most VS peritonitis episodes were completely cured regardless of a history of peritonitis. All episodes with catheter removal occurred in those without a history of recent antibiotic use.
Conclusion:
VS peritonitis in patients undergoing PD typically has favorable treatment outcomes. Antibiotic therapy should be started promptly.
Insights
Viridans streptococci peritonitis in peritoneal dialysis patients generally has good outcomes. Prompt antibiotic treatment is crucial for successful management of this infection.
Area of Science:
- Nephrology
- Infectious Diseases
- Microbiology
Background:
- Viridans streptococci (VS) peritonitis is a rare complication in patients undergoing peritoneal dialysis (PD).
- Limited data exists on the clinical course and factors associated with VS peritonitis in PD patients.
Purpose of the Study:
- To investigate the clinical factors associated with Viridans streptococci peritonitis.
- To evaluate the clinical profiles and treatment outcomes of VS peritonitis in PD patients.
Main Methods:
- Retrospective review of clinical data from PD patients with VS peritonitis.
- Data collected from March 1990 to February 2016 at a Taiwanese PD center.
- Analysis of 109 episodes in 71 patients, including mono-VS and polymicrobial infections.
Main Results:
- Most VS peritonitis episodes demonstrated favorable treatment outcomes, with complete cure rates high, irrespective of prior peritonitis history.
- The median time from PD initiation to the first VS peritonitis episode was 18 months.
- Catheter removal was exclusively observed in patients without recent antibiotic use.
Conclusions:
- Viridans streptococci peritonitis in PD patients typically exhibits favorable treatment outcomes.
- Prompt initiation of antibiotic therapy is recommended for effective management.
Related Concept Videos
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Peritoneal Dialysis I: Introduction and Procedure
Peritoneal Dialysis III: Nursing Management
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Dialysis

